We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

32 hedge funds and large institutions have $13.7M invested in ImmuCell in 2026 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

14% more funds holding

Funds holding: 28 → 32 (+4)

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

0.4% less ownership

Funds ownership: 15.43% → 15.03% (-0.4%)

24% less capital inflows, than outflows

Capital inflows: $893K | Capital outflows: $1.18M

Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$170K
2
Jane Street
Jane Street
New York
+$139K
3
Quadrature Capital
Quadrature Capital
United Kingdom
+$136K
4
Morgan Stanley
Morgan Stanley
New York
+$108K
5
Mercer Global Advisors
Mercer Global Advisors
Colorado
+$106K

Top Sellers

Rank Fund Capital Flow
1
Bleichroeder LP
Bleichroeder LP
New York
-$456K
2
Northern Trust
Northern Trust
Illinois
-$238K
3
Shufro Rose & Co
Shufro Rose & Co
New York
-$221K
4
Steadtrust
Steadtrust
Texas
-$79.5K
5
Militia Capital Management
Militia Capital Management
Texas
-$70.7K

ICCC Hedge Fund Activity: Q2 2026 in Review

32 of the 8,372 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2026, worth a combined $13.7M — up 55% from $8.84M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ICCC positions and 3 closed out — a net gain of 4 holders — while 8 added to existing stakes and 7 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $170K. The largest seller was Bleichroeder LP, cutting an estimated $456K.

  • 32 institutional investors held ImmuCell (ICCC) as of Q2 2026, up from 28 in Q1 2026.
  • Funds reported $13.7M of ImmuCell stock for Q2 2026, up 55% quarter-over-quarter.
  • 7 funds opened new ImmuCell positions in Q2 2026 and 3 closed out, a net change of +4 holders.
  • The largest ImmuCell buyer in Q2 2026 was Renaissance Technologies, an estimated $170K added.
  • The largest ImmuCell seller in Q2 2026 was Bleichroeder LP, an estimated $456K sold.

Based on aggregated 13F filings for Q2 2026.